Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 25.34% Profit Margin: A Victory for QuantWave

May 09, 2025
REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit margin of 25.34%. The forecast signal was issued on February 26, 2025, with a predicted direction of short at a price of 705.9 $. The target price was achieved on May 9, 2025, with the stock hitting 527.0 $.

This achievement showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. Market analysis suggests that factors such as regulatory approvals, clinical trial outcomes, and overall market sentiment may have contributed to the stock's movement.

QuantWave's automated forecasting platform offers users the opportunity to access predictions for a wide range of stocks, providing potential opportunities for profits. For those interested in delving deeper into investment strategies, QuantSchool offers comprehensive educational resources to understand the key principles of generating consistent income using QuantWave's forecasting system.

Find out how the REGENERON PHARMACEUTICALS, INC. rate is expected to change

Get Forecast for REGN
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for REGN

REGNMay 9, 2025QuantWave Forecast Achieves 24.9% Profit Target for Regeneron Pharmaceuticals, Inc. Stock  ~1 min.

Regeneron Pharmaceuticals, Inc. stock recently saw the successful achievement of a price target forecast as predicted by QuantWave's automated forecasting platform....

REGNMay 9, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Forecast Price Target with a Profit of 24.47%  ~1 min.

On February 28, 2025, QuantWave's forecasting system signaled a short position for REGENERON PHARMACEUTICALS, INC. stock when the price was at 697.71 $....

REGNApril 12, 2025Regeneron Pharmaceuticals Receives Dupixent Approval in Japan  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has recently received approval for its drug Dupixent in Japan....

REGNApril 10, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.79% Profit: QuantWave's Success  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 17.79%....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....



Related news

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target Forecast with a Profit of 17.34%  ~1 min.

On January 23, 2025, QuantWave, the automated forecasting platform, issued a short forecast signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at 692.73 $....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....

REGNAugust 13, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 14.62%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast as predicted by QuantWave's automated forecasting platform....

REGNAugust 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin  ~1 min.

On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....

REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 18.25% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved to be highly accurate, as the stock reached the predicted target price of 1172.09 $ on August 15, 2024, from the signal price of 991....